Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
In the MASLD (metabolic dysfunction-associated steatotic liver disease) substudy, participants on the 12 mg dose achieved greater than 85% liver fat normalization
In the SCALE Obesity and Prediabetes trial (N=3,731), participants receiving liraglutide 3.0 mg daily lost a mean of 8.0% of body weight over 56 weeks, compared with 2.6% in the placebo group [1]
We do not upload your personal information to external servers
GoalBMI Wellness offers physician-guided peptide therapy in New York through secure telehealth consultations for eligible adults
US$ 27.13
US$ 27.93
US$ 23.16
US$ 21.58
